LEXX · Lexaria Bioscience Corp.
Substantial doubt about the company's ability to continue as a going concern.
“The recurring losses and negative net cash flows raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Jul 13, 2026
One customer — 100% of revenue (nine months ended May 31, 2026)
“In the nine months ended May 31, 2026, the Company recognized revenue of $20,000 on a consolidated basis. One customer accounted for 100% of that total.”
2 customers — 100% of revenue (nine months ended May 31, 2025)
“In the nine months ended May 31, 2025, the Company recognized revenue of $531,923 on a consolidated basis. Two customers accounted for 100% of that total.”
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
LEXX Latest Reported Short Interest
FINRA reported 27,867 LEXX shares sold short as of the August 14, 2026 settlement date, an increase of 11,602 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent stock splits
LEXX Short Interest Forecast
Equibles' model estimates 29,509 shares sold short for the August 31, 2026 settlement, +5.9% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.
Expected Aug 31 short interest
as of Aug 21Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-09-15
Scheduled
FINRA publishes Sep 24
|
— | — | — | — |
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
| 2026-08-14 | 27,867 | 16,265 | +11,602 | 1.00 |
| 2026-07-31 | 16,265 | 10,904 | +5,361 | 1.40 |
| 2026-07-15 | 10,904 | 22,875 | -11,971 | 2.80 |
| 2026-06-30 | 22,875 | 24,030 | -1,155 | 5.27 |
| 2026-06-15 | 24,030 | 23,345 | +685 | 4.54 |
| 2026-05-29 | 23,345 | 25,459 | -2,114 | 3.75 |
| 2026-05-15 | 25,459 | 23,080 | +2,379 | 2.51 |
| 2026-04-30 | 23,080 | 25,527 | -2,447 | 1.44 |
| 2026-04-15 | 25,527 | 18,868 | +6,659 | 1.56 |
| 2026-03-31 | 18,868 | 24,873 | -6,005 | 1.91 |
| 2026-03-13 | 24,873 | 25,593 | -720 | 2.30 |
| 2026-02-27 | 25,593 | 43,521 | -17,928 | 3.91 |
| 2026-02-13 | 43,521 | 42,080 | +1,441 | 3.14 |
| 2026-01-30 | 42,080 | 70,429 | -28,349 | 4.52 |
| 2026-01-15 | 70,429 | 106,449 | -36,020 | 3.45 |
| 2025-12-31 | 106,449 | 41,213 | +65,236 | 1.00 |
| 2025-12-15 | 41,213 | 40,337 | +876 | 1.97 |
| 2025-11-28 | 40,337 | 43,435 | -3,098 | 4.29 |
| 2025-11-14 | 43,435 | 49,405 | -5,970 | 2.81 |
| 2025-10-31 | 49,405 | 66,720 | -17,315 | 3.10 |
| 2025-10-15 | 66,720 | 71,527 | -4,807 | 2.32 |
| 2025-09-30 | 71,527 | 28,765 | +42,762 | 1.00 |
| 2025-09-15 | 28,765 | 27,443 | +1,322 | 2.84 |
Full FINRA short interest reporting calendar